Home » Topics » Disease categories and therapies » Musculoskeletal

Musculoskeletal
RSS

PLA2 inhibitors remain a focus of research at Genetics Institute

Oct. 6, 1999

rhPM-1 inhibits synovial cell proliferation in vitro, inflammatory cell infiltration in vivo

Oct. 5, 1999

British Biotech moves novel rheumatoid arthritis treatment into development

Oct. 4, 1999

Cytokine inhibitors from Ortho-McNeil and methods of treating rheumatoid arthritis, etc.

Oct. 4, 1999

American Cyanamid presents newest MMP inhibitors

Oct. 1, 1999

Phospholipase inhibitors synthesized and tested at Genetics Institute

Sep. 30, 1999

Hydroxamic acid-based inhibitors of TNF-alpha production under study at Yoshitomi

Sep. 30, 1999

New compounds for inflammatory conditions from Genetics Institute act by inhibiting PLA2

Sep. 29, 1999

Celltech reports discovery of alpha4 integrin inhibitors

Sep. 28, 1999

Selective COX-2 inhibitors from UPSA useful for inflammatory and painful conditions

Sep. 28, 1999

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 9, 2026.
‘Target-high but uptake-defective’ state identified in ADC resistance
BioWorld
Separate research teams have reported new insights into resistance mechanisms to the antibody-drug conjugate (ADC) Padcev (enfortumab vedotin, Astellas Pharma...
Hyperexcitability may be joint problem in epilepsy, dementia
BioWorld
The majority of epilepsies are developmental disorders that start in childhood. But there is a large minority that starts in late adulthood. And increasingly,...
Neurovalens granted FDA approval for PTSD therapy for US veterans
BioWorld
Veterans in the U.S. suffering from post-traumatic stress disorder (PTSD) now have access to Neurovalens Ltd.’s Modius Spero, a wearable neuromodulation device,...
FENS 2026: Shedding light on the sheddome
BioWorld
At the recently opened FENS Forum 2026 in Barcelona – the Federation of European Neuroscience Societies’ flagship congress and Europe’s largest neuroscience...